Scientific article

Multicenter evaluation of light transmission platelet aggregation reagents: communication from the ISTH SSC Subcommittee on Platelet Physiology

Published inJournal of thrombosis and haemostasis, vol. 21, no. 9, p. 2596-2610
Publication date2023-09
First online date2023-06-16

Background: Light transmission aggregation (LTA) is used widely by the clinical and research communities. Although it is a gold standard, there is a lack of interlaboratory harmonization.

Objectives: The primary objective was to assess whether sources of activators (mainly adenosine diphosphate [ADP], collagen, arachidonic acid, epinephrine, and thrombin receptor activating peptide6) and ristocetin contribute to poor LTA reproducibility. The secondary objective was to evaluate interindividual variability of results to appreciate the distribution of normal values and consequently better interpret pathologic results.

Methods: An international multicenter study involving 28 laboratories in which we compared LTA results obtained with center-specific activators and a comparator that we supplied.

Results: We report variability in the potency (P) of activators in comparison with the comparator. Thrombin receptor activating peptide 6 (P, 1.32-2.68), arachidonic acid (P, 0.87-1.43), and epinephrine (P, 0.97-1.34) showed the greatest variability. ADP (P, 1.04-1.20) and ristocetin (P, 0.98-1.07) were the most consistent. The data highlighted clear interindividual variability, notably for ADP and epinephrine. Four profiles of responses were observed with ADP from high-responders, intermediate-responders, and low-responders. A fifth profile corresponding to nonresponders (5% of the individuals) was observed with epinephrine.

Conclusion: Based on these data, the establishment and adoption of simple standardization principles should mitigate variability due to activator sources. The observation of huge interindividual variability for certain concentrations of activators should lead to a cautious interpretation before reporting a result as abnormal. Confidence can be taken from the fact that difference between sources is not exacerbated in patients treated with antiplatelet agents.

  • Activators
  • Aggregation
  • Multicenter
  • Platelets
  • Standardization
  • Humans
  • Platelet Aggregation
  • Ristocetin
  • Arachidonic Acid / pharmacology
  • Reproducibility of Results
  • Adenosine Diphosphate / pharmacology
  • Platelet Function Tests / methods
  • Platelet Aggregation Inhibitors / pharmacology
  • Epinephrine / pharmacology
  • Communication
  • Blood Platelets
Citation (ISO format)
ALESSI, Marie-Christine et al. Multicenter evaluation of light transmission platelet aggregation reagents: communication from the ISTH SSC Subcommittee on Platelet Physiology. In: Journal of thrombosis and haemostasis, 2023, vol. 21, n° 9, p. 2596–2610. doi: 10.1016/j.jtha.2023.05.027
Main files (1)
Article (Published version)
Secondary files (1)
ISSN of the journal1538-7836

Technical informations

Creation04/12/2024 4:09:56 PM
First validation05/03/2024 3:07:37 PM
Update time05/03/2024 3:07:37 PM
Status update05/03/2024 3:07:37 PM
Last indexation05/03/2024 3:07:57 PM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack